Clinical Trials
5 trialsNCT04655118 2024-05-10
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
Telios Pharma, Inc.
Phase 2 Unknown
NCT04333108 2023-05-06
Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment
AB Science
Phase 3 Unknown
NCT01602939 2016-08-29
Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis
Hospital Virgen de la Salud
Phase 2/3 Unknown
NCT01920204 2015-01-19
Midostaurin in Indolent Systemic Mastocytosis
University Medical Center Groningen
Phase 2 Unknown
NCT00979160 2009-09-18
Evaluation of Response of Dasatinib to Treat Mastocytosis
Federico II University
Phase 2 Unknown